Koyfin Home > Directory > Health Care > Aduro Biotech > Altman Z-score

Aduro Biotech Altman Z-score Chart (ADRO)

Aduro Biotech annual/quarterly Altman Z-score from 2013 to 2020.
  • Aduro Biotech Altman Z-score for the quarter ending June 06, 2020 was -2.02 a 11.03% decrease of -0.22 year over year
  • Aduro Biotech Altman Z-score for the last 12 months ending June 06, 2020 was -2.28 a 32.34% decrease of -0.74 year over year
  • Aduro Biotech Annual Altman Z-score for 2019 was -1.95 a 87.78% decrease of -1.71 from 2018
  • Aduro Biotech Annual Altman Z-score for 2018 was -0.24 a 666.46% decrease of -1.59 from 2017
  • Aduro Biotech Annual Altman Z-score for 2017 was 1.35 a -73.91% decrease of -1.00 from 2016
Other Balance Sheet Metrics:
  • Aduro Biotech Total Assets for the quarter ending December 12, 2018 was $358m a -18.27% decrease of -65m year over year
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Equity for the quarter ending December 12, 2018 was $135m a -45.56% decrease of -62m year over year
View Chart On Koyfin

Quarterly ADRO Altman Z-score Data

06/2020-2.02
03/2020-1.38
12/2019-2.18
09/2019-1.80
06/2019-1.14
03/2019-0.94
12/2018-0.74
09/2018-0.02
06/20180.39
03/20180.63

Annual ADRO Altman Z-score Data

2019-1.95
2018-0.24
20171.35
20162.35
20155.41
2014-0.31
2013-11.71
2012-16.52